Any current/future new fundraising through debt or equity?

Currently, Max India Limited is well-funded and does not have any immediate plans for capital raising. Rajit Mehta mentioned that the company could consider raising capital in the future as scale-up and growth progress, but no confirmation has been made yet. No specific details were provided on timelines or amounts for any future debt or equity fundraising. The INR 330 crores approved infusion is internal allocation mainly for Antara Assisted Care and residential vertical, not an external fundraising.

Any current/future capex/capital investment/strategic investment?

Approved capex of INR 330 crores allocated primarily to Antara Assisted Care and residential verticals. INR 180 crores earmarked for Antara Assisted Care and related businesses including Care Homes and AGEasy. INR 150 crores allocated to residential projects such as new communities in Gurgaon and Bengaluru. Investment focus on expanding bed capacity with ~600 new beds expected next year (Gurgaon, Bengaluru, Noida, Chennai, Whitefield). Significant investment in human capital, marketing, and technology platforms for scaling up businesses like AGEasy. Ongoing launches: Gurgaon intergen

Future growth expectations in sales/revenue/volumes?

FY25 outlook: Strong double-digit growth expected in Care at Home segment due to deeper market penetration in Bengaluru, Chennai, and NCR. Care Homes: Planned significant expansion with 600 beds operational by FY25 year-end, including launches in Bengaluru (Bannerghatta), Noida, Gurgaon, and Whitefield. AGEasy platform: Rapid growth with ARR of INR 6 crores within 6 months; expects further scale-up and improved contribution margins. MedCare: Continues strong growth driven by product customization and expanded offline and online channels, including Amazon, contributing to 100% YoY revenue growt

Future growth expectations in earnings/operating earnings/profits/EPS?

FY24 saw strong revenue growth across verticals; however, consolidated EBITDA showed a loss of INR 34 crores due to expansion and scale-up investments. Expansion year in FY25: Plans to add ~600 care home beds, launch new communities in Gurgaon and Bengaluru, and expand Care at Home in NCR, Bengaluru, Chennai. Expected occupancy ramp-up in care homes (targeting 70-75%) could lead to contribution margins of around 23-24%. MedCare and AGEasy are scaling up with significant revenue growth (MedCare 100% YoY, AGEasy with INR 6 cr ARR within 6 months). Marketing spends remain elevated (~7-8%) to supp

Current/ Expected Orderbook/ Pending Orders?

The company is actively expanding its orderbook with multiple projects under various stages: - Gurugram community: Prelaunch activities ongoing; RERA approval application submitted; 0.72 million sq ft senior living with 292 apartments; expected launch in Q2 FY25. - Bengaluru community: Definitive agreements closed; financial closure pending; 1.08 million sq ft development with 544 units; expected launch in Q4 FY25. - Additional projects: Advanced discussions underway for Hyderabad, Chandigarh, and other geographies. Care Homes expansion: - 600 beds targeted by FY25 year-end. - Curre

Max India LtdQ4 FY24Finance

Max India Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹163Market Cap: ₹917 CrSector: Finance

Management growth scorecard

Revenue

Category 2

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

FY25 outlook: Strong double-digit growth expected in Care at Home segment due to deeper market penetration in Bengaluru, Chennai, and NCR.
Care Homes: Planned significant expansion with 600 beds operational by FY25 year-end, including launches in Bengaluru (Bannerghatta), Noida, Gurgaon, and Whitefield.
AGEasy platform: Rapid growth with ARR of INR 6 crores within 6 months; expects further scale-up and improved contribution margins.
MedCare: Continues strong growth driven by product customization and expanded offline and online channels, including Amazon, contributing to 100% YoY revenue growth.
Assisted Living Communities: New projects in Gurugram and Bengaluru with expected launches in FY25; targeting 1.5 million sq ft development annually for next 3-4 years.
Overall: Expansion phase with upfront investments; management confident growth and margin improvement will manifest by years 3-4 as scale increases.

Margin guidance

FY24 saw strong revenue growth across verticals; however, consolidated EBITDA showed a loss of INR 34 crores due to expansion and scale-up investments.
Expansion year in FY25: Plans to add ~600 care home beds, launch new communities in Gurgaon and Bengaluru, and expand Care at Home in NCR, Bengaluru, Chennai.
Expected occupancy ramp-up in care homes (targeting 70-75%) could lead to contribution margins of around 23-24%.
MedCare and AGEasy are scaling up with significant revenue growth (MedCare 100% YoY, AGEasy with INR 6 cr ARR within 6 months).
Marketing spends remain elevated (~7-8%) to support growth and brand building.
No immediate capital raise planned but possible as scale-up continues.
Profitability expected to improve by years 3-4 as expansions mature, backed by scalable unit economics seen in Gurgaon Care Home.
Focus on operational efficiency and high-margin services to sustain growth and margins.

See what Max India Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Currently, Max India Limited is well-funded and does not have any immediate plans for capital raising.
Rajit Mehta mentioned that the company could consider raising capital in the future as scale-up and growth progress, but no confirmation has been made yet.
No specific details were provided on timelines or amounts for any future debt or equity fundraising.
The INR 330 crores approved infusion is internal allocation mainly for Antara Assisted Care and residential vertical, not an external fundraising.

Order book

The company is actively expanding its orderbook with multiple projects under various stages:
- Gurugram community: Prelaunch activities ongoing; RERA approval application submitted; 0.72 million sq ft senior living with 292 apartments; expected launch in Q2 FY25.
- Bengaluru community: Definitive agreements closed; financial closure pending; 1.08 million sq ft development with 544 units; expected launch in Q4 FY25.
- Additional projects: Advanced discussions underway for Hyderabad, Chandigarh, and other geographies.
Care Homes expansion:
- 600 beds targeted by FY25 year-end.
- Current beds under fit-out: 83 beds in Bengaluru (Bannerghatta), 53 beds in Noida, 98 beds in Gurgaon, and 85 beds in Whitefield (LOIs signed, construction RFPs out).
Antara Assisted Care expects to add 225 beds across locations by Q2 FY25 and Q3 FY25, indicating a strong pipeline of operational assets ready to launch.

See what Max India Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Approved capex of INR 330 crores allocated primarily to Antara Assisted Care and residential verticals.
INR 180 crores earmarked for Antara Assisted Care and related businesses including Care Homes and AGEasy.
INR 150 crores allocated to residential projects such as new communities in Gurgaon and Bengaluru.
Investment focus on expanding bed capacity with ~600 new beds expected next year (Gurgaon, Bengaluru, Noida, Chennai, Whitefield).
Significant investment in human capital, marketing, and technology platforms for scaling up businesses like AGEasy.
Ongoing launches: Gurgaon intergenerational project (0.72 million sq. ft., 292 units) in Q2 FY25 and Bengaluru project (1.08 million sq. ft., 544 units) expected in Q4 FY25.
Further development of physical infrastructure and specialized teams for multiple disease conditions.
Potential future capital raise possible as scale-up progresses, but not planned currently.

Track Max India Ltd — get its next earnings analysis in your feed

How does Max India Ltd rank vs peers in Finance?

Pro feature

ThisMax India Ltd

Rev 2

See where Max India Ltd sits in FinanceSee which companies these are, and every other name in the sector.Open rankings

How does Max India Ltd rank in Finance?

Compare Max India Ltd against every Finance company (Q4 FY24) on revenue, margins and earnings-call signals.

View Finance leaderboard →

What Max India Ltd's management said in earlier quarters

Others in Finance this season

SRG Housing Finance Ltd (Q1 FY27)
Profit after tax has shown strong growth of 33% in the financial year 2025-2026 and 25% in the recent quarter, indicating upward momentum. Key concall…
Moneyboxx Finance Ltd (Q1 FY27)
Monthly debt requirement around INR80 crores will continue to support disbursements and growth. Key concall takeaways from Moneyboxx Finance Ltd's Q1 FY27…
Nisus Finance Services Co Ltd (Q1 FY27)
Q1 FY27 Consolidated Revenue:** ₹184.49 Cr, up from ₹28.40 Cr in Q1 FY26 (approx. Key investor presentation takeaways from Nisus Finance Services Co Ltd's Q1 FY
CRISIL Ltd (Q2 FY25)
Q3 2024 Income from operations: ₹811.8 crore, up 10.3% YoY (Page 12) . Key concall takeaways from CRISIL Ltd's Q2 FY25 earnings call — and how it ranks against…

Compare:vs Bajaj Finserv vs Tata Capital vs Cholaman.Inv.&Fn

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →